In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Kevin Damman
Speaker
Kevin Damman
Kevin Damman Kevin Damman

University Medical Center Groningen, Groningen (Netherlands (The))

Specialities : Acute Heart Failure , Acute Cardiac Care, Device Therapy

Dr Kevin Damman, MD, PhD, FHFA, studied medicine at the University of Groningen, The Netherlands and received his PhD in 2009 entitled “Cardiorenal Interaction in Heart Failure”. Dr Damman is a clinical cardiologist, head of the heart transplant and ventricular assist device program at the University Medical Center Groningen. His interests include advanced and acute heart failure. Current research interests are focused on improving treatment of acute heart failure patients, including SGLT2-inhibition in (acute) heart failure and the role of the kidney in the process of cardiorenal interaction. He is principle investigator of the EMPA-RESPONSE-AHF study on empagliflozin in acute heart failure and is part of the steering committee of the ADVOR trial investigating acetazolamide in acute heart failure. Dr Damman is associate editor of the European Journal of Heart Failure and is member of the working groups on Cardiorenal Dysfunction and Acute Heart Failure from the HFA.

14 presentations from this speaker

The role of SGLT2 inhibitors in patients without diabetes.

Event : ESC Congress 2020

  • Session : Managing Heart Failure in 2020 – Insights from the Experts
  • Speaker : K Damman (Groningen,NL)

A practical approach to diuretic use in heart failure.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : K Damman (Groningen,NL), A Mebazaa (Paris,FR), W Mullens (Genk,BE)

Cardiorenal syndrome.

Event : Heart Failure 2019

  • Session : Acute heart failure: does clinical settings matter?
  • Speaker : K Damman (Groningen,NL)

Evolution of left ventricular assist device therapy: time for reappraisal?

Event : Heart Failure 2019

  • Session : Fighting advanced heart failure with innovative medical device technology
  • Speaker : K Damman (Groningen,NL)
  • Sponsored by Abbott

Chronic kidney disease

Event : Heart Failure 2018

  • Session : Managing comorbidities in heart failure
  • Speaker : K Damman (Groningen,NL)

Diuretic resistance.

Event : Heart Failure 2017

  • Session : How to tackle congestion
  • Speaker : K Damman (Groningen,NL)

Cardiorenal syndrome.

Event : Heart Failure 2016

  • Session : Organ dysfunction in acute heart failure
  • Speaker : K Damman (Groningen,NL)

Is the patient decongested?

Event : Heart Failure 2016

  • Session : How to tackle congestion in heart failure
  • Speaker : K Damman (Groningen,NL)

Angiotensin receptor neprilysin inhibition and renal function and in heart failure: results from PARADIGM-HF

Event : ESC Congress 2015

  • Session : Advances in heart failure therapy
  • Speaker : K Damman (Groningen,NL)

Diuretic resistance.

Event : Heart Failure 2015

  • Session : Challenging cases in acute heart failure
  • Speaker : K Damman (Groningen,NL)

Kidney disease.

Event : Heart Failure 2015

  • Session : Co-morbidities in acute heart failure
  • Speaker : K Damman (Groningen,NL)

Renal biomarkers.

Event : Heart Failure 2015

  • Session : How to interpret biomarkers in heart failure
  • Speaker : K Damman (Groningen,NL)

Heart failure and renal impairment: helping the heart, sparing the kidneys.

Event : ESC Congress 2013

  • Session : Heart failure: solving difficult problems
  • Speaker : K Damman (Groningen,NL)

Panel discussion.

Event : ESC Congress 2013

  • Session : Heart failure: solving difficult problems
  • Speaker : K Damman (Groningen,NL), RS Gardner (Linithgow,GB), EA Jankowska (Wroclaw,PL)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are